EQUILIBRE Trademark

Trademark Overview


On Tuesday, March 16, 2021, a trademark application was filed for EQUILIBRE with the United States Patent and Trademark Office. The USPTO has given the EQUILIBRE trademark a serial number of 90581710. The federal status of this trademark filing is REGISTERED as of Tuesday, May 30, 2023. This trademark is owned by Equilibre Biopharmaceuticals Corp.. The EQUILIBRE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, pharmaceutical preparations and pharmaceutical agents for treatment of neurodegenerative diseases, acute inflammatory conditions, and not for use in connection with the treatment of urological or urinary tract diseases and disorders
equilibre

General Information


Serial Number90581710
Word MarkEQUILIBRE
Filing DateTuesday, March 16, 2021
Status700 - REGISTERED
Status DateTuesday, May 30, 2023
Registration Number7069162
Registration DateTuesday, May 30, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2022

Trademark Statements


Goods and ServicesPharmaceuticals, pharmaceutical preparations and pharmaceutical agents for treatment of neurodegenerative diseases, acute inflammatory conditions, and not for use in connection with the treatment of urological or urinary tract diseases and disorders
Translation of Words in MarkThe English translation of "EQUILIBRE" in the mark is "EQUILIBRIUM" and/or "BALANCE".

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 16, 2021
Primary Code005
First Use Anywhere DateTuesday, June 15, 2021
First Use In Commerce DateWednesday, February 8, 2023

Trademark Owner History


Party NameEQUILIBRE BIOPHARMACEUTICALS B.V.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAmsterdam 1017 CG
NL

Party NameEQUILIBRE BIOPHARMACEUTICALS B.V.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAmsterdam 1017 CG
NL

Party NameEQUILIBRE BIOPHARMACEUTICALS CORP.
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressAMSTERDAM 1017 CG
NL

Party NameEquilibre Biopharmaceuticals Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events


Event DateEvent Description
Tuesday, May 30, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 30, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, April 25, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, April 24, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 17, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 1, 2023USE AMENDMENT FILED
Friday, March 17, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 1, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, September 14, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, September 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 29, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 23, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, June 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 25, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 1, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 1, 2021NON-FINAL ACTION E-MAILED
Monday, November 1, 2021NON-FINAL ACTION WRITTEN
Sunday, October 17, 2021ASSIGNED TO EXAMINER
Wednesday, June 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 19, 2021NEW APPLICATION ENTERED